BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24057314)

  • 21. Detection of drugs in saliva of impaired drivers.
    Peel HW; Perrigo BJ; Mikhael NZ
    J Forensic Sci; 1984 Jan; 29(1):185-9. PubMed ID: 6366113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and validation of the Cozart DDS oral fluid collection device.
    Speedy T; Baldwin D; Jowett G; Gallina M; Jehanli A
    Forensic Sci Int; 2007 Aug; 170(2-3):117-20. PubMed ID: 17624706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detecting alcohol and illicit drugs in oral fluid samples collected from truck drivers in the state of São Paulo, Brazil.
    Yonamine M; Sanches LR; Paranhos BA; de Almeida RM; Andreuccetti G; Leyton V
    Traffic Inj Prev; 2013; 14(2):127-31. PubMed ID: 23343020
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance evaluation of on-site oral fluid drug screening devices in normal police procedure in Germany.
    Musshoff F; Hokamp EG; Bott U; Madea B
    Forensic Sci Int; 2014 May; 238():120-4. PubMed ID: 24699311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009).
    Gjerde H; Christophersen AS; Normann PT; Assum T; Oiestad EL; Mørland J
    Traffic Inj Prev; 2013; 14(5):443-52. PubMed ID: 23697895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concentrations of cocaine and its major metabolite benzoylecgonine in blood samples from apprehended drivers in Sweden.
    Jones AW; Holmgren A; Kugelberg FC
    Forensic Sci Int; 2008 May; 177(2-3):133-9. PubMed ID: 18164886
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cocaine and benzoylecgonine concentrations in fluorinated plasma samples of drivers under suspicion of driving under influence.
    Musshoff F; Madea B
    Forensic Sci Int; 2010 Jul; 200(1-3):67-72. PubMed ID: 20456881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of driving with blood drug concentrations above proposed new legal limits in Norway: estimations based on drug concentrations in oral fluid.
    Gjerde H; Normann PT; Christophersen AS; Mørland J
    Forensic Sci Int; 2011 Jul; 210(1-3):221-7. PubMed ID: 21482055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An analytical evaluation of eight on-site oral fluid drug screening devices using laboratory confirmation results from oral fluid.
    Blencowe T; Pehrsson A; Lillsunde P; Vimpari K; Houwing S; Smink B; Mathijssen R; Van der Linden T; Legrand SA; Pil K; Verstraete A
    Forensic Sci Int; 2011 May; 208(1-3):173-9. PubMed ID: 21183299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in drivers testing positive for drugs of abuse in oral fluid from 2018 to 2021 in France.
    Willeman T; Bartolli M; Jourdil JF; Vial S; Eysseric-Guérin H; Stanke-Labesque F
    Forensic Sci Int; 2023 Nov; 352():111835. PubMed ID: 37748427
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drugs in oral fluid Part II. Investigation of drugs in drivers.
    Wylie FM; Torrance H; Seymour A; Buttress S; Oliver JS
    Forensic Sci Int; 2005 Jun; 150(2-3):199-204. PubMed ID: 15944060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concentrations of drugs determined in blood samples collected from suspected drugged drivers in England and Wales.
    Burch HJ; Clarke EJ; Hubbard AM; Scott-Ham M
    J Forensic Leg Med; 2013 May; 20(4):278-89. PubMed ID: 23622475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor.
    Fucci N; De Giovanni N; De Giorgio F; Liddi R; Chiarotti M
    Forensic Sci Int; 2006 Jan; 156(2-3):102-5. PubMed ID: 16410159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection and prevalence of drug use in arrested drivers using the Dräger Drug Test 5000 and Affiniton DrugWipe oral fluid drug screening devices.
    Logan BK; Mohr AL; Talpins SK
    J Anal Toxicol; 2014 Sep; 38(7):444-50. PubMed ID: 24894458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of psychoactive substances in oral fluid from randomly selected drivers in Denmark.
    Simonsen KW; Steentoft A; Hels T; Bernhoft IM; Rasmussen BS; Linnet K
    Forensic Sci Int; 2012 Sep; 221(1-3):33-8. PubMed ID: 22554868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Laboratory evaluation and field application of roadside oral fluid collectors and drug testing devices.
    Crouch DJ; Walsh JM; Cangianelli L; Quintela O
    Ther Drug Monit; 2008 Apr; 30(2):188-95. PubMed ID: 18367979
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Roadside detection of impairment under the influence of ketamine--evaluation of ketamine impairment symptoms with reference to its concentration in oral fluid and urine.
    Cheng WC; Ng KM; Chan KK; Mok VK; Cheung BK
    Forensic Sci Int; 2007 Jul; 170(1):51-8. PubMed ID: 17046188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drugs in injured drivers in Denmark.
    Bernhoft IM; Steentoft A; Johansen SS; Klitgaard NA; Larsen LB; Hansen LB
    Forensic Sci Int; 2005 Jun; 150(2-3):181-9. PubMed ID: 15944058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DUID: oral fluid and blood confirmation compared in Belgium.
    Van der Linden T; Legrand SA; Silverans P; Verstraete AG
    J Anal Toxicol; 2012 Jul; 36(6):418-21. PubMed ID: 22577111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recommendations for toxicological investigation of drug impaired driving.
    Farrell LJ; Kerrigan S; Logan BK
    J Forensic Sci; 2007 Sep; 52(5):1214-8. PubMed ID: 17680796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.